Design and synthesis of 4-benzyl-1-(2H)-phthalazinone derivatives as novel androgen receptor antagonists.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European journal of medicinal chemistry

• Publication date

  2015-09-18

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejmech.2015.08.002PMID 26295173
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural classification of steroid-binding sites on proteins by coarse-grained atomic environment and its correlation with their biological function.

  2015cited by this paper
• SAR based design of nicotinamides as a novel class of androgen receptor antagonists for prostate cancer.

  2013cited by this paper
• Design and Synthesis of 4-(4-Benzoylaminophenoxy)phenol Derivatives As Androgen Receptor Antagonists.

  2013cited by this paper
• How community has shaped the Protein Data Bank.

  2013cited by this paper
• Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.

  2011cited by this paper
• Phthalazinone pyrazoles as potent, selective, and orally bioavailable inhibitors of Aurora-A kinase.

  2011cited by this paper
• Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC).

  2010cited by this paper
• Study of the impact of the T877A mutation on ligand‐induced helix‐12 positioning of the androgen receptor resulted in design and synthesis of novel antiandrogens

  2010cited by this paper
• 4-(Anilino)pyrrole-2-carboxamides: Novel non-steroidal/non-anilide type androgen antagonists effective upon human prostate tumor LNCaP cells with mutated nuclear androgen receptor.

  2008cited by this paper
• GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.

  2008cited by this paper
• Targeting the androgen receptor pathway in prostate cancer.

  2008cited by this paper
• 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1.

  2008cited by this paper
• Androgen receptor: role and novel therapeutic prospects in prostate cancer

  2008cited by this paper
• Chemistry and structural biology of androgen receptor.

  2005cited by this paper
• Structural basis for antagonism and resistance of bicalutamide in prostate cancer

  2005cited by this paper
• Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.

  2004cited by this paper
• Molecular basis for the antiandrogen withdrawal syndrome

  2004cited by this paper
• Anti-androgens with full antagonistic activity toward human prostate tumor LNCaP cells with mutated androgen receptor.

  2003cited by this paper
• Broadened ligand responsiveness of androgen receptor mutants obtained by random amino acid substitution of H874 and mutation hot spot T877 in prostate cancer

  2002cited by this paper
• Gene regulation through chromatin remodelling by members of the nuclear receptor superfamily.

  2000cited by this paper
• An update on bicalutamide in the treatment of prostate cancer.

  1999cited by this paper
• Androgen Metabolism and Prostate Cancer: Establishing a Model of Genetic Susceptibility

  1998cited by this paper
• Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility.

  1998cited by this paper
• Androgens in men--uses and abuses.

  1996cited by this paper
• Hormone-refractory (D3) prostate cancer: refining the concept.

  1995cited by this paper
• Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation.

  1992cited by this paper
• The steroid and thyroid hormone receptor superfamily.

  1988cited by this paper
• Inhibitory and stimulatory effects of glucocorticoid on androgen-induced growth of murine Shionogi carcinoma 115 in vivo and in cell culture.

  1987cited by this paper
• Biological actions of androgens.

  1987cited by this paper
• 7-(Ethoxycarbonyl)-6,8-dimethyl-2-phenyl-1(2H)-phthalazinone derivatives: synthesis and inhibitory effects on platelet aggregation.

  1984cited by this paper
• Isochino[3,2‐a]phthalazin‐5,8‐dione

  1982cited by this paper
• A biological profile of a nonsteroidal antiandrogen, SCH 13521 (4'-nitro-3'trifluoromethylisobutyranilide).

  1972cited by this paper
• Preparation of a Substituted 1,2-Benzofluorenone: An Unusual Perkin Reaction1a

  1958cited by this paper

• Design, synthesis and anti-tumor evaluation of novel thiohydantoin congeners as androgen receptor antagonists with in vivo study

  2024cites this paper
• Microwave-assisted synthesis, characterization, and molecular docking studies of new chlorophthalazine derivatives as anticancer activity

  2024cites this paper
• Discovery of Orally Bioavailable Phthalazinone Analogues as an ENPP1 Inhibitor for STING-Mediated Cancer Immunotherapy.

  2023cites this paper
• Recyclable Silver-Catalyzed Selective Hydrogenation of Imides to Primary Amines via Dual C-N Bond Cleavage.

  2023cites this paper
• Therapeutic Strategies to Target the Androgen Receptor.

  2022cites this paper
• Microwave‐Assisted Synthesis of Phthalazinone Derivatives with Biological Activity and In Silico Antiproliferative Studies

  2022cites this paper
• Recent developments in the green synthesis of biologically relevant cinnolines and phthalazines

  2022cites this paper
• Palladium-Catalyzed Direct α-Arylation of Indane-1,3-dione to 2-Substituted Indene-1,3-diones.

  2021cites this paper
• Zeolite-based hybrid material as an efficient promoter in the green synthesis of mono/bis-phthalazinones

  2021cites this paper
• Facile and Efficient Nitration of 4‐Aryl‐1( 2H )‐Phthalazinone Derivatives Using Different Catalysts

  2021cites this paper
• Proposal of novel potent inhibitors against androgen receptor based on ab initio molecular orbital calculations.

  2021cites this paper
• The design, synthesis and anti-tumor mechanism study of new androgen receptor degrader.

  2020cites this paper
• Development of Androgen-Antagonistic Coumarinamides with a Unique Aromatic Folded Pharmacophore

  2020cites this paper
• Brief Overview on Biological Potential of Various Substituted Phthalazine and Phthalazinone Analogues

  2019cites this paper
• Cubane Electrochemistry: Direct Conversion of Cubane Carboxylic Acids to Alkoxy Cubanes Using the Hofer–Moest Reaction under Flow Conditions

  2019cites this paper
• Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in Prostate Cancer.

  2019cites this paper
• Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents.

  2019cites this paper
• Pharmacological activities of various phthalazine and phthalazinone derivatives

  2019cites this paper
• Recent advances in the synthesis of phthalazin-1(2H)-one core as a relevant pharmacophore in medicinal chemistry.

  2019cites this paper
• Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.

  2018cites this paper
• Design and synthesis of indoline thiohydantoin derivatives based on enzalutamide as antiproliferative agents against prostate cancer.

  2017cites this paper
• Specific interactions between androgen receptor and its ligand: ab initio molecular orbital calculations in water.

  2017cites this paper
• Spectroscopic investigations (FT-IR, UV, 1H and 13C NMR) and DFT/TD-DFT calculations of potential analgesic drug 2-[2-(dimethylamino)ethyl]-6-methoxy-4-(pyridin-2-yl)-1(2H)-phthalazinone

  2017cites this paper
• Synthesis of Novel Phthalazine Derivatives as Potential Anticancer and Antioxidant Agents Based on 1‐Chloro‐4‐(4‐phenoxyphenyl)phthalazine

  2017cites this paper
• Development of N-(4-Phenoxyphenyl)benzenesulfonamide Derivatives as Novel Nonsteroidal Progesterone Receptor Antagonists.

  2016cites this paper
• Design and synthesis of novel androgen receptor antagonists via molecular modeling.

  2016cites this paper